AR041891A1 - Empleo de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones causadas por el virus de la influenza - Google Patents

Empleo de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones causadas por el virus de la influenza

Info

Publication number
AR041891A1
AR041891A1 ARP030104047A ARP030104047A AR041891A1 AR 041891 A1 AR041891 A1 AR 041891A1 AR P030104047 A ARP030104047 A AR P030104047A AR P030104047 A ARP030104047 A AR P030104047A AR 041891 A1 AR041891 A1 AR 041891A1
Authority
AR
Argentina
Prior art keywords
resveratrol
preparation
treatment
employment
influenza virus
Prior art date
Application number
ARP030104047A
Other languages
English (en)
Spanish (es)
Inventor
Enrico Garaci
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of AR041891A1 publication Critical patent/AR041891A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP030104047A 2002-11-06 2003-11-05 Empleo de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones causadas por el virus de la influenza AR041891A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000562A ITRM20020562A1 (it) 2002-11-06 2002-11-06 Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.

Publications (1)

Publication Number Publication Date
AR041891A1 true AR041891A1 (es) 2005-06-01

Family

ID=32310188

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030104047A AR041891A1 (es) 2002-11-06 2003-11-05 Empleo de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones causadas por el virus de la influenza

Country Status (18)

Country Link
US (1) US8431617B2 (https=)
EP (1) EP1567137B1 (https=)
JP (1) JP4589118B2 (https=)
KR (1) KR101060331B1 (https=)
AR (1) AR041891A1 (https=)
AT (1) ATE381929T1 (https=)
AU (1) AU2003279551A1 (https=)
CA (1) CA2504872C (https=)
CY (1) CY1107302T1 (https=)
DE (1) DE60318327T2 (https=)
DK (1) DK1567137T3 (https=)
ES (1) ES2295660T3 (https=)
IT (1) ITRM20020562A1 (https=)
MX (1) MXPA05004628A (https=)
PL (1) PL217628B1 (https=)
PT (1) PT1567137E (https=)
TW (1) TWI337863B (https=)
WO (1) WO2004041260A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1951285A2 (en) * 2005-11-18 2008-08-06 Ares Trading S.A. Interferon in influenza
EP2268272A2 (en) * 2008-03-06 2011-01-05 Mount Sinai School of Medicine of New York University Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof
WO2010053949A1 (en) * 2008-11-04 2010-05-14 Metaproteomics, Llc Phytochemical compositions and methods for activating amp-kinase
US20110236349A1 (en) * 2008-12-19 2011-09-29 Koff Jonathan L Use of Epidermal Growth Factor Inhibitors in the Treatment of Viral Infection
KR100950445B1 (ko) 2009-10-26 2010-04-02 주식회사 중앙백신연구소 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제
WO2011150413A1 (en) 2010-05-28 2011-12-01 Mount Sinai School Of Medicine Antiviral compounds and uses thereof
CA2850597A1 (en) * 2011-09-30 2013-04-04 Vanderbilt University Antiviral therapies with phospholipase d inhibitors
EP2952209B1 (en) 2014-06-04 2018-03-28 Alfasigma S.p.A. Homogeneous formulations comprising omega-3 polyunsaturated fatty acids (n-3 PUFA) and resveratrol for oral administration
EP2952180B1 (en) 2014-06-04 2017-01-25 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Solid formulations containing resveratrol and omega-3 polyunsaturated fatty acids (n-3 PUFA)
EP3120842A1 (en) * 2015-07-20 2017-01-25 Opterion Health AG Peritoneal therapeutic fluid
KR20170039456A (ko) 2015-10-01 2017-04-11 동아대학교 산학협력단 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물
JP2018024592A (ja) * 2016-08-09 2018-02-15 株式会社ブレインヘルス 抗生物質含有組成物
CN108893558B (zh) * 2018-05-24 2022-04-05 江苏海宏制药有限公司 一种桑木液原液抗病毒实验方法以及装置
EP4132277B1 (en) * 2020-04-05 2025-11-26 Mong, Michael Systems and methods for treating coronavirus
WO2026044308A1 (en) 2024-08-26 2026-03-05 Medizinische Universität Wien Treatment and prevention of diseases caused by influenza virus with 3,3',4,4',5,5'-hexahydroxy-trans-stilbene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2778337B1 (fr) 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
PE20010540A1 (es) 1999-07-30 2001-05-15 Procter & Gamble Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza
DE60015568D1 (de) * 1999-08-13 2004-12-09 Univ Maryland Biotech Inst Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür

Also Published As

Publication number Publication date
JP2006507295A (ja) 2006-03-02
TW200501935A (en) 2005-01-16
TWI337863B (en) 2011-03-01
PL217628B1 (pl) 2014-08-29
JP4589118B2 (ja) 2010-12-01
KR20050071627A (ko) 2005-07-07
US20050239906A1 (en) 2005-10-27
CA2504872C (en) 2011-07-05
CY1107302T1 (el) 2012-11-21
AU2003279551A1 (en) 2004-06-07
US8431617B2 (en) 2013-04-30
EP1567137A1 (en) 2005-08-31
ATE381929T1 (de) 2008-01-15
PT1567137E (pt) 2008-02-19
DE60318327T2 (de) 2008-12-18
CA2504872A1 (en) 2004-05-21
ES2295660T3 (es) 2008-04-16
PL377557A1 (pl) 2006-02-06
WO2004041260A1 (en) 2004-05-21
EP1567137B1 (en) 2007-12-26
ITRM20020562A1 (it) 2004-05-07
DE60318327D1 (de) 2008-02-07
MXPA05004628A (es) 2005-09-08
DK1567137T3 (da) 2008-04-28
KR101060331B1 (ko) 2011-08-30

Similar Documents

Publication Publication Date Title
AR041891A1 (es) Empleo de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones causadas por el virus de la influenza
CL2021001810A1 (es) Combinación de dextrometorfano y bupropión para el tratamiento de depresión
EA201101518A1 (ru) Фармацевтическая композиция для применения в медицинской и ветеринарной офтальмологии
BR0309083A (pt) Compostos derivados de benzoxazinona, sua preparação e uso como medicamentos
MX2012007410A (es) Compuestos antivirales novedosos.
BR112014009851A2 (pt) moduladores de receptor de nmda e usos dos mesmos
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
DE69906518D1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
BR112023000270A2 (pt) Composto, composição farmacêutica, e, peptídeo
BR112015018168A2 (pt) inibidores de rock suaves
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
BR112015030315A2 (pt) derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
BR102013003570A8 (pt) Composições de plasma rico em plaquetas
ATE543804T1 (de) Neue verbindungen
BR0207738A (pt) Sistema terapêutico transdermal altamente flex–vel com nicotina como subst ncia ativa
CL2008001820A1 (es) Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer.
AR054249A1 (es) Tratamiento de enfermedades del tejido conectivo de la piel
AR045783A1 (es) Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
BRPI0519351A2 (pt) medicamentos para o tratamento ou prevenÇço de doenÇas fibràticas
BRPI0407140A (pt) Droga terapêutica para vìrus
BRPI0413101A (pt) compostos de sulfonamida derivado de benzoxazinona, sua preparação e uso como medicamentos
AR036518A1 (es) Nuevos medicamentos para la inhalacion
EP4302799A4 (en) DEVICE FOR ADMINISTRATING A PHARMACEUTICAL LIQUID

Legal Events

Date Code Title Description
FB Suspension of granting procedure